|
1）Elliott MJ, De Coppi P, Speggiorin S, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet. 2012; 380: 994-1000
|
|
|
|
2）Weiss DJ, Casaburi R, Flannery R, et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest. 2013; 143: 1590-8
|
|
|
|
|
|
3）Petersen TH, Calle EA, Zhao L, et al. Tissue-engineered lungs for in vivo implantation. Science. 2010; 329: 538-41
|
|
|
|
|
|
4）Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med. 2010; 16: 927-33
|
|
|
|
|
|
5）Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861-72
|
|
|
|
|
|
6）Kotton DN, Morrisey EE. Lung regeneration: mechanisms, applications and emerging stem cell populations. Nat Med. 2014; 20: 822-32
|
|
|
|
|
|
7）Wong AP, Bear CE, Chin S, et al. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nat Biotechnol. 2012; 30: 876-82
|
|
|
|
|
|
8）Lachmann N, Happle C, Ackermann M, et al. Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2014; 189: 167-82
|
|
|
|
|
|
9）Suzuki T, Mayhew C, Sallese A, et al. Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis. Am J Respir Crit Care Med. 2014; 189: 183-93
|
|
|
|
|
|
10）D’Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006; 24: 1392-401
|
|
|
|
|
|
11）Sullivan GJ, Hay DC, Park IH, et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology. 2010; 51: 329-35
|
|
|
|
|
|
12）Green MD, Chen A, Nostro MC, et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat Biotechnol. 2011; 29: 267-72
|
|
|
|
|
|
13）Hrvatin S, O’Donnell CW, Deng F, et al. Differentiated human stem cells resemble fetal, not adult, β cells. Proc Natl Acad Sci U S A. 2014; 111: 3038-43
|
|
|
|
|
|
14）Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459: 262-5
|
|
|
|
|
|
15）Spence JR, Mayhew CN, Rankin SA, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2011; 470: 105-9
|
|
|
|
|
|
16）Takebe T, Sekine K, Enomura M, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013; 499: 481-4
|
|
|
|
|
|
17）Gotoh S, Ito I, Nagasaki T, et al. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem Cell Reports. 2014; 3: 394-403
|
|
|
|
|
|
18）Pagliuca FW, Millman JR, Gürtler M, et al. Generation of functional human pancreaticβcells in vitro. Cell. 2014; 159: 428-39
|
|
|
|
|
|
19）McCracken KW, Catá EM, Crawford CM, et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature. 2014; 516: 400-4
|
|
|
|
|
|
20）Dye BR, Hill DR, Ferguson MA, et al. In vitro generation of human pluripotent stem cell derived lung organoids. Elife. 2015; 4: e05098
|
|
|
|
|
|
21）Watson CL, Mahe MM, Múnera J, et al. An in vivo model of human small intestine using pluripotent stem cells. Nat Med. 2014; 20: 1310-14
|
|
|
|
|
|
22）Finkbeiner SR, Hill DR, Altheim CH, et al. Transcriptome-wide analysis reveals hallmarks of human intestine development and maturation in vitro and in vivo. Stem Cell Reports. 2015; 4: 1140-55
|
|
|
|
|
|
23）Huang SX, Islam MN, O’Neill J, et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol. 2014; 32: 84-91
|
|
|
|
|
|
24）Mou H, Zhao R, Sherwood RI, et al. Generation of multipotent embryonic lung and airway progenitors from pluripotent stem cells. Cell Stem Cell. 2012; 10: 385-97
|
|
|
|
|
|
25）Firth AL, Dargitz CT, Qualls SJ, et al. Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2014; 111: E1723-30
|
|
|
|
|
|
26）Ghaedi M, Calle EA, Mendez JJ, et al. Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix. J Clin Invest. 2013; 123: 4950-62
|
|
|
|
|
|
27）Barkauskas CE, Cronce MJ, Rackley CR, et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest. 2013; 123: 3025-36
|
|
|
|
|
|
28）Gonzalez RF, Allen L, Gonzales L, et al. HTII-280, a biomarker specific to the apical plasma membrane of human lung alveolar type II cells. J Histochem Cytochem. 2010; 58 : 891-901
|
|
|
|
|
|
29）Miki K, Endo K, Takahashi S, et al. Efficient detection and purification of cell populations using synthetic microRNA switches. Cell Stem Cell. 2015; 16: 699-711
|
|
|
|
|
|
30）Khurana V, Tardiff DF, Chung CY, et al. Toward stem cell-based phenotypic screens for neurodegenerative diseases. Nat Rev Neurol. 2015; 11: 339-50
|
|
|
|
|
|
31）Höing S, Rudhard Y, Reinhardt P, et al. Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay. Cell Stem Cell. 2012; 11: 620-32
|
|
|
|
|
|
32）Stem cell reports. http://www.cell.com/stem-cell-reports/authors
|
|
|
|
|
|
33）Sterneckert JL, Reinhardt P, Schöler HR. Investigating human disease using stem cell models. Nat Rev Genet. 2014; 15: 625-39
|
|
|
|
|
|
34）Crane AM, Kramer P, Bui JH, et al. Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells. Stem Cell Reports. 2015; 4: 569-77
|
|
|
|
|
|
35）Yusa K, Rashid ST, Strick-Marchand H, et al. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature. 2011; 478: 391-4
|
|
|
|
|
|
36）Wilson AA, Ying L, Liesa M, et al. Emergence of a stage-dependent human liver disease signature with directed differentiation of alpha-1 antitrypsin-deficient iPS cells. Stem Cell Reports. 2015; 4: 873-85
|
|
|
|
|
|
37）Hugun, Izumi S, Miyazawa H, et al. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med. 2007; 175: 263-8
|
|
|
|
|
|
38）Gilpin SE, Ren X, Okamoto T, et al. Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix. Ann Thorac Surg. 2014; 98: 1721-9
|
|
|
|
|
|
39）Sasai Y. Cytosystems dynamics in self-organization of tissue architecture. Nature. 2013; 493: 318-26
|
|
|
|
|
|
40）Eiraku M, Watanabe K, Matsuo-Takasaki M, et al. Self-organized formation of polarized cortical tissues from ES cells and its active manipulation by extrinsic signals. Cell Stem Cell. 2008; 3: 519-32
|
|
|
|
|
|
41）Nakano T, Ando S, Takata N, et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell. 2012; 10: 771-85
|
|
|
|
|
|
42）Taguchi A, Kaku Y, Ohmori T, et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell. 2014; 14: 53-67
|
|
|
|
|
|
43）Takebe T, Enomura M, Yoshizawa E, et al. Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell. 2015; 16: 556-65
|
|
|
|
|